1
|
Yau JW, Lee P, Wong TY, Best J and Jenkins
A: Retinal vein occlusion: An approach to diagnosis, systemic risk
factors and management. Intern Med J. 38:904–910. 2008.PubMed/NCBI View Article : Google Scholar
|
2
|
Pierru A, Girmens JF, Héron E and Paques
M: Retinal vein occlusions. J Fr Ophtalmol. 40:696–705.
2017.PubMed/NCBI View Article : Google Scholar : (In French).
|
3
|
Jaulim A, Ahmed B, Khanam T and
Chatziralli IP: Branch retinal vein occlusion: Epidemiology,
pathogenesis, risk factors, clinical features, diagnosis, and
complications. An update of the literature. Retina. 33:901–910.
2013.PubMed/NCBI View Article : Google Scholar
|
4
|
Feltgen N and Pielen A: [Retinal vein
occlusion: Epidemiology, classification and clinical findings].
Ophthalmologe. 112:607–618; quiz 619-620. 2015.PubMed/NCBI View Article : Google Scholar : (In German).
|
5
|
Ehlers JP, Kim SJ, Yeh S, Thorne JE,
Mruthyunjaya P, Schoenberger SD and Bakri SJ: Therapies for macular
edema associated with branch retinal vein occlusion: A report by
the American Academy of Ophthalmology. Ophthalmology.
124:1412–1423. 2017.PubMed/NCBI View Article : Google Scholar
|
6
|
Spaide RF: Retinal vascular cystoid
macular edema: Review and new theory. Retina. 36:1823–1842.
2016.PubMed/NCBI View Article : Google Scholar
|
7
|
Campochiaro PA, Heier JS, Feiner L, Gray
S, Saroj N, Rundle AC, Murahashi WY and Rubio RG: BRAVO
Investigators. ranibizumab for macular edema following branch
retinal vein occlusion: Six-month primary end point results of a
phase III study. Ophthalmology. 117:1102–1112.e1. 2010.PubMed/NCBI View Article : Google Scholar
|
8
|
Tadayoni R, Waldstein SM, Boscia F,
Gerding H, Gekkieva M, Barnes E, Das Gupta A, Wenzel A and Pearce
I: BRIGHTER Study Group. Sustained benefits of ranibizumab with or
without laser in branch retinal vein occlusion: 24-month results of
the BRIGHTER Study. Ophthalmology. 124:1778–1787. 2017.PubMed/NCBI View Article : Google Scholar
|
9
|
Daruich A, Matet A, Moulin A, Kowalczuk L,
Nicolas M, Sellam A, Rothschild PR, Omri S, Gélizé E, Jonet L, et
al: Mechanisms of macular edema: Beyond the surface. Prog Retin Eye
Res. 63:20–68. 2018.PubMed/NCBI View Article : Google Scholar
|
10
|
Chen CH, Chen YH, Wu PC, Chen YJ, Lee JJ,
Liu YC and Kuo HK: Treatment of branch retinal vein occlusion
induced macular edema in treatment-naïve cases with a single
intravitreal triamcinolone or bevacizumab injection. Chang Gung Med
J. 33:424–435. 2010.PubMed/NCBI
|
11
|
Feng J, Zhao T, Zhang Y, Ma Y and Jiang Y:
Differences in aqueous concentrations of cytokines in macular edema
secondary to branch and central retinal vein occlusion. PLoS One.
8(e68149)2013.PubMed/NCBI View Article : Google Scholar
|
12
|
Xia JP, Wang S and Zhang JS: The
anti-inflammatory and anti-oxidative effects of conbercept in
treatment of macular edema secondary to retinal vein occlusion.
Biochem Biophys Res Commun. 508:1264–1270. 2019.PubMed/NCBI View Article : Google Scholar
|
13
|
Sun Z, Zhou H, Lin B, Jiao X, Luo Y, Zhang
F, Tao S, Wu Q, Ke Z and Liu X: Efficacy and safety of intravitreal
Conbercept injections in macular edema secondary to retinal vein
occlusion. Retina. 37:1723–1730. 2017.PubMed/NCBI View Article : Google Scholar
|
14
|
Tang F, Qin X, Lu J, Song P, Li M and Ma
X: Optical coherence tomography predictors of short-term visual
acuity in eyes with macular edema secondary to retinal vein
occlusion treated with intravitreal conbercept. Retina: Jan 10,
2019 (Epub ahead of print).
|
15
|
Luo W, Jia F, Liu M, Wang Y and Zhang T:
The analysis of correlative factors of visual acuity with
intravitreal Conbercept injection in macular edema associated with
branch retinal vein occlusion. J Ophthalmol.
2018(7348153)2018.PubMed/NCBI View Article : Google Scholar
|
16
|
Tadayoni R, Waldstein SM, Boscia F,
Gerding H, Pearce I, Priglinger S, Wenzel A, Barnes E, Gekkieva M,
Pilz S, et al: BRIGHTER study group: Individualized stabilization
criteria-driven ranibizumab versus laser in branch retinal vein
occlusion: Six-month results of BRIGHTER. Ophthalmology.
123:1332–1344. 2016.PubMed/NCBI View Article : Google Scholar
|
17
|
Brown DM, Ou WC, Wong TP, Kim RY, Croft DE
and Wykoff CC: DAVE Study Group. Targeted retinal photocoagulation
for diabetic macular edema with peripheral retinal nonperfusion:
Three-year randomized DAVE trial. Ophthalmology. 125:683–690.
2018.PubMed/NCBI View Article : Google Scholar
|
18
|
Yan M, Huang Z, Lian HY, Song YP and Chen
X: Conbercept for treatment of choroidal neovascularization
secondary to pathologic myopia. Acta Ophthalmol. 97:e813–e814.
2019.PubMed/NCBI View Article : Google Scholar
|
19
|
Lang GE, Liakopoulos S, Vögeler J, Weiß C,
Spital G, Gamulescu MA, Lohmann C and Wiedemann P: The RELATION
study: Efficacy and safety of ranibizumab combined with laser
photocoagulation treatment versus laser monotherapy in NPDR and PDR
patients with diabetic macular oedema. Acta Ophthalmol.
96:e377–e385. 2018.PubMed/NCBI View Article : Google Scholar
|
20
|
Ishibashi T, Li X, Koh A, Lai TY, Lee FL,
Lee WK, Ma Z, Ohji M, Tan N, Cha SB, et al: REVEAL Study Group: The
REVEAL Study: Ranibizumab monotherapy or combined with laser versus
laser monotherapy in Asian patients with diabetic macular edema.
Ophthalmology. 122:1402–1415. 2015.PubMed/NCBI View Article : Google Scholar
|
21
|
Januschowski K, Feltgen N, Pielen A,
Spitzer B, Rehak M, Spital G, Dimopoulos S, Meyer CH and Szurman
GB: Bevacizumab Study Group Venous Occlusion. Predictive factors
for functional improvement following intravitreal bevacizumab
injections after central retinal vein occlusion. Graefes Arch Clin
Exp Ophthalmol. 255:457–462. 2017.PubMed/NCBI View Article : Google Scholar
|
22
|
Theodossiadis PG, Grigoropoulos VG and
Theodossiadis GP: The significance of the external limiting
membrane in the recovery of photoreceptor layer after successful
macular hole closure: A study by spectral domain optical coherence
tomography. Ophthalmologica. 225:176–184. 2011.PubMed/NCBI View Article : Google Scholar
|
23
|
Inoue M, Watanabe Y, Arakawa A, Sato S,
Kobayashi S and Kadonosono K: Spectral-domain optical coherence
tomography images of inner/outer segment junctions and macular hole
surgery outcomes. Graefes Arch Clin Exp Ophthalmol. 247:325–330.
2009.PubMed/NCBI View Article : Google Scholar
|